Meribank Biotech Co (ROCO:4724) EV-to-Revenue : 8.37 (As of Jan. 18, 2025)

Meribank Biotech Co EV-to-Revenue Chart

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-Revenue	Get a 7-Day Free Trial								-	-	-	9.85	-

Competitive Comparison of Meribank Biotech Co's EV-to-Revenue

For the Biotechnology subindustry, Meribank Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meribank Biotech Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Meribank Biotech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Meribank Biotech Co's EV-to-Revenue falls into.

Meribank Biotech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Meribank Biotech Co's EV-to-Revenue for today is calculated as:

Meribank Biotech Co's current Enterprise Value is NT$2,188.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meribank Biotech Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was NT$261.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co  (ROCO:4724) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Meribank Biotech Co's PS Ratiofor today is calculated as:

Meribank Biotech Co's share price for today is NT$23.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was NT$3.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co Business Description